5-HT2

This MedLibrary.org supplementary page on 5-HT2 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

5-HT2 receptors are a family of 5-HT receptors, with the following members:

Multiple receptor subtypes of serotonin (5-HT) neurotransmitters with multiple physiologic functions have been recognized. The 5-HT-2 receptors mediate many of the central and peripheral physiologic functions of serotonin. Cardiovascular effects include contraction of blood vessels and shape changes in platelets; central nervous system effects include neuronal sensitization to tactile stimuli and mediation of hallucinogenic effects of phenylisopropylamine hallucinogens. [1]

Contents

5-HT2A receptors
 

Main article: 5-HT2A receptor

This is the main excitatory receptor subtype among the GPCRs for serotonin (5-HT), although 5-HT2A may also have an inhibitory effect on certain areas such as the visual cortex and the orbitofrontal cortex. This receptor was given importance first as the target of psychedelic drugs like LSD. Later it came back to prominence because it was also found to be mediating, at least partly, the action of many antipsychotic drugs, especially the atypical ones.

5-HT2A also happens to be a necessary receptor for the spread of the human polyoma virus called JC virus.

Function Agonists Antagonists
  • CNS: neuronal excitation, behavioural effects, learning, anxiety
  • smooth muscle: contraction, vasoconstriction / vasodilatation
  • platelets: aggregation

5-HT2B receptors

Main article: 5-HT2B receptor
Function Agonists Antagonists

5-HT2C receptors

Main article: 5-HT2C receptor
Function Agonists      Antagonists     

References

  1. ^ [supplied by OMIM] "Entrez Gene: HTR2B 5-hydroxytryptamine (serotonin) receptor 2B".
  2. ^ M. J. Millan, A. Gobert, F. Lejeune, A. Dekeyne, A. Newman-Tancredi, V. Pasteau, J.-M. Rivet & D. Cussac (September 2003). "The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways". The Journal of Pharmacology and Experimental Therapeutics 306 (3): 954–954. doi:10.1124/jpet.103.051797. PMID 12750432. 

Other

  • Bryan L .Roth, David L. Willins, Kurt Kristiansen & Wesley K. Kroeze (1998). "5-Hydroxytryptamine2-Family Receptors (Hydroxytryptamine2A Hydroxytryptamine2B, Hydroxytryptamine2C): Where Structure Meets Function". Pharmacol. Ther. 79 (3): 321–257. 

Wikipedia content modification information:

  • This page was last modified on 9 October 2008, at 09:57.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "5-HT2".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.